MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-10-2026
Exagen EBITDA per Share 2011-2026 | XGN
Annual EBITDA per Share Exagen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.56 | -0.66 | -1.17 | -2.6 | -1.45 | -1.16 | -2.43 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.56 | -2.6 | -1.43 |
Quarterly EBITDA per Share Exagen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.11 | -0.1 | -0.16 | - | -0.23 | -0.12 | -0.14 | - | -0.25 | -0.25 | -0.41 | - | -0.43 | -0.81 | -0.55 | - | -0.37 | -0.33 | -0.41 | - | -0.29 | -0.25 | -0.41 | - | -1.36 | -35 | -26.6 | - | -14.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.1 | -35 | -3.79 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 15.85 | -2.49 % | $ 171 M |  China |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M |  USA |
 |
Agilent Technologies
A
|
5.49 | $ 115.06 | -0.29 % | $ 35 B | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-4.37 | $ 1.13 | -2.59 % | $ 6.15 M | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 16.05 | -3.83 % | $ 855 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 2.3 | - | $ 10.2 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
0.89 | $ 23.13 | -1.28 % | $ 642 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 175.65 | 0.06 % | $ 8.71 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 493.53 | -1.59 % | $ 14.2 B | USA |
 |
Danaher Corporation
DHR
|
7.63 | $ 189.61 | -1.7 % | $ 135 B | USA |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-3.01 | $ 120.93 | -2.22 % | $ 19.2 B | USA |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 4.35 | -2.03 % | $ 403 M | USA |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 14.43 | -3.93 % | $ 436 M | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 7.69 | -3.17 % | $ 985 M | USA |
 |
Guardant Health
GH
|
-3.17 | $ 78.6 | -9.83 % | $ 9.85 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
-361 | $ 2.69 | -1.82 % | $ 87.3 K | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.13 | -0.9 % | $ 4.89 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
0.61 | $ 28.31 | 0.62 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 106.81 | 0.1 % | $ 8.81 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M |  Israel |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 260.93 | -4.51 % | $ 21.7 B | USA |
 |
Natera
NTRA
|
-5.33 | $ 193.03 | -4.91 % | $ 19 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 117.14 | -6.02 % | $ 5.48 B | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 80.59 | -1.03 % | $ 5.44 B | USA |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 6.68 | 0.15 % | $ 279 M | USA |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
Soleno Therapeutics
SLNO
|
0.22 | $ 52.63 | 0.23 % | $ 2.67 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 191.51 | -3.19 % | $ 21.3 B | USA |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.42 | -6.13 % | $ 2.04 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-7.27 | $ 4.94 | -6.97 % | $ 3.89 M | USA |
 |
Neuronetics
STIM
|
-0.42 | $ 1.35 | -2.17 % | $ 89 M | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 16.48 | -3.34 % | $ 369 M | USA |